US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Oct. 28 for "Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use" (Maryland, Washington, Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,780, issued on Oct. 28, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use" was invented by Javed Khan (Derwood, Md.), Sivasubramanian Baskar (Ellicott City, Md.), Rimas J. Orentas (Seattle), Dimiter S. Dimitrov (Pittsburgh), Zhongyu Zhu (Frederick, Md.) and Tai Chi Cheuk (Germantown, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Monoclonal antibodies selected from immunized mice, immunized rabbits and a human scFv library that specifically bind fibroblast g...